pharma · Aplastic Anemia · Advanced Hepatocellular Carcinoma
Kyowa Kirin International
KYOWA KIRIN AUSTRALIA PTY LTD
KYOWA KIRIN AUSTRALIA is a pharma organization headquartered in AU. Primary therapeutic focus areas include Aplastic Anemia, Advanced Hepatocellular Carcinoma, Advanced or Recurrent Breast Cancer, Moderate to Severe Plaq
GB HQ
1995 Founded
690 Employees
TGA registrant Type
Company details
- Status
- Public
- HQ
- GB
- Founded
- 1995
- Employees
- 690
- Programs
- 15
- Drugs
- 12
- Patents
- 0
2223-001
Phase 1 · other · T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)
2223-001 for T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL) is a Phase 1 program (other) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code 2223-001
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- KYOWA KIRIN AUSTRALIA PTY LTD
- Phase
- Phase 1
- Modality
- other
- Indication
- T-cell Non-Hodgkin Lymphoma, Cutaneous T-cell lymphoma (CTCL), Peripheral T-cell lymphoma (PTCL)
- Status
- active
- Trials
- 1